The Effects of L-arabinose on Intestinal Sucrase Activity in Man

Status Completed

Clinical Trial Summary

The purpose of this study is to investigate the effect of L-arabinose in a sugar-rich meal on intestinal sucrase activity in healthy volunteers by measuring postprandial blood glucose and insulin, and selected intestinal hormonal responses to increasing doses of L-arabinose.

Clinical Trial Description

Background:

The intake of common table sugar (sucrose) in the industrialised countries is relatively high. In Denmark the daily intake of sugar is in the range of 30-40 g/d exclusive the intake of sugar containing drinks. The health consequences of this relatively high sugar intake are heavily debated in the media. One of the arguments is that a high sugar intake may be one of the factors involved in the development of the metabolic syndrome, including overweight, increased blood glucose and insulin levels as well as impaired insulin action.

L-arabinose is widely distributed in plants and is a common component in plant cell walls in maize, wheat, rye, rice, plant gums etc. The isolated 5-carbon sugar has been shown to suppress the increase of blood glucose and plasma insulin after ingestion of sucrose in rats by inhibition of sucrase activity. In vitro studies on Caco-2 cells indicate that L-arabinose is a potent inhibitor on sucrase activity, possibly in a non-competitive way.

Potential nutritional advantages of consuming L-arabinose in combination with sucrose may therefore be a delayed digestion of sucrose and a lower absorption of glucose, resulting in both lower blood glucose and insulin levels. A delayed digestion of sucrose will reduce the energy utilisation with the potential of reducing weight gain in human subjects.

Methods:

This dose-response study with 14 healthy male volunteers has a randomised cross-over design based on four single "meals" separated by one week wash-out periods. Sugar rich drinks supplemented with different doses of L-arabinose will be tested with respect to postprandial blood glucose, insulin, triglyceride, glucose-dependent insulinotropic peptide (GIP) and glucagon-like peptide-1 (GLP-1). Postprandial blood samples will be taken every 15 to 30 min for 180 min. Appetite sensations will be measured every 30 min during the experiment. After 180 minutes a lunch will be served and energy intake (EI) will be registered. ;

Study Design

Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Double Blind (Subject, Caregiver), Primary Purpose: Prevention

Related Conditions & MeSH terms

Blood Glucose

Clinical Trial Details

NCT number	NCT00302302
Study type	Interventional
Source	University of Copenhagen
Contact
Status	Completed
Phase	Phase 1
Start date	September 2005
Completion date	January 2006

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT04578067` - Empowering Immigrant Women for Active and Healthy Lifestyle	N/A
Completed	`NCT04256746` - Dose Response Study of a Natural Extract for Reducing Post Prandial Blood Glucose	N/A
Completed	`NCT03254082` - Glycemic Response of Sorghum	N/A
Completed	`NCT02536066` - Daily Physical Activity After Meals -Long Term Effects on Blood Glucose	N/A
Completed	`NCT00444171` - Glucose Control by eMPC Algorithm in Peri- and Postoperative Period in Cardiac Surgery Patients	N/A
Completed	`NCT04378374` - The Effect of Pulse Flours on Blood Glucose, Satiety and Food Intake	N/A
Completed	`NCT04451655` - Glycemic Stability During the Intraoperative Period Among Patients With DM Undergoing CABG Surgery	N/A
Recruiting	`NCT04989712` - MOReS Freestyle Libre Validation Study	N/A
Completed	`NCT05352724` - Clinical Trial to Evaluate the Efficacy of a Sport Drink After High-intensity Aerobic Exercise	N/A
Completed	`NCT04260425` - A Pilot Study Evaluating Oat Polyphenols on Post-prandial Glucose Response	N/A
Completed	`NCT04258501` - Exploratory Study of Efficacy on Selected Natural Extracts Reducing Post Prandial Blood Glucose Response	N/A
Completed	`NCT02968498` - Blood Glucose Response After Oral Intake of Lactulose in Healthy Volunteers	N/A
Completed	`NCT02484313` - The Effect of Snacks on Glycaemic Regulation in Children	N/A
Withdrawn	`NCT01246492` - The Effect of Artificial Sweeteners on Blood Glucose Response	N/A
Completed	`NCT01241253` - Glycemic Response of Bean-and-rice Meals in Type 2 Diabetes Mellitus	Phase 2
Completed	`NCT03914430` - Breakfast Cereals Consumed in Dairy and Non-dairy Medium: the Effects on Blood Glucose, Satiety and Food Intake	N/A
Recruiting	`NCT05255783` - The Performance of Dexcom G6 Glucose Monitoring in Critically Ill Patients	N/A
Completed	`NCT05573607` - Effects of a Dietary Supplement on Markers of Glucose Control and Quality of Life	N/A
Recruiting	`NCT05585801` - Continuous Glucose Monitoring in Intensive Care Unit	N/A
Active, not recruiting	`NCT03978104` - Impact of Okara and Bio-okara Food Product on Gut and Glycaemic Health in Middle-aged and Older Adults in Singapore	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.